{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T22:30:39Z","timestamp":1768689039195,"version":"3.49.0"},"reference-count":31,"publisher":"Scientific Scholar","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2017,4]]},"abstract":"<jats:sec>\n            <jats:title>Background &amp; objectives:<\/jats:title>\n            <jats:p>The enzyme paraoxonase (PON), an antioxidant enzyme that has both arylesterase and thiolactonase activity, is well studied in cardiovascular diseases. Although a few studies have shown altered PON activity in ocular diseases such as age-related macular degeneration and diabetic retinopathy, but the tissue-wise expression of PON in its three gene forms has not been studied. This study was conducted to see the ocular distribution of PON for any altered expression in ocular pathologies such as in cataract and diabetes mellitus.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Immunohistochemistry (IHC) of the ocular tissues was done for localizing all three forms of the PON in the human donor eyeballs. The PON arylesterase (PON-AREase) and thiolactonase (PON-HCTLase) activities were determined by spectrophotometry in kinetic mode, and the mRNA expression of the PON genes (<jats:italic toggle=\"yes\">PON1-3<\/jats:italic>) was determined by reverse transcription-polymerase chain reaction.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>IHC showed the presence of both PON1 and 2 in all the ocular tissues and PON3 was seen only in retina. The mRNA expression analysis showed that PON2 and PON3 were present in all the tissues, whereas PON1 was seen only in ciliary and retina. Both the PON-AREase and PON-HCTLase activities were detected in all ocular tissues and was in the order of lens&gt;retina&gt;choroid&gt;ciliary body&gt;iris. The expression and activity were studied in cataractous lens and in diabetic retina of the donor eyes. A significant decrease in PON-AREase activity was seen in cataractous lens (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.05) but not in diabetic retina, and there was an increase in PON- HCTLase activity (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.05) only in diabetic retina. Bioinformatic studies and <jats:italic toggle=\"yes\">in vitro<\/jats:italic> experiments indicated that advanced glycation end products (AGE) such as carboxymethyl -lysine might decrease the PON- AREase activity of the PON.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interpretation &amp; conclusions:<\/jats:title>\n            <jats:p>Distribution of PON enzyme and its activity in ocular tissues is reported here. The study revealed maximal PON activity in lens and retina, which are prone to higher oxidative stress. Differential activities of PON were observed in the lens and retinal tissues from cataractous and diabetic patients, respectively.<\/jats:p>\n          <\/jats:sec>","DOI":"10.4103\/ijmr.ijmr_1284_14","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T19:02:54Z","timestamp":1734634974000},"page":"513-520","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Ocular distribution of antioxidant enzyme paraoxonase &amp; its alteration in cataractous lens &amp; diabetic retina"],"prefix":"10.25259","volume":"145","author":[{"given":"Subramaniam Rajesh","family":"Bharathidevi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kannadasan Anand","family":"Babu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishit","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sivashanmugam","family":"Muthukumaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vetrivel","family":"Umashankar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narayanasamy","family":"Angayarkanni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","reference":[{"key":"R1-14-20241212","doi-asserted-by":"crossref","first-page":"122","DOI":"10.11613\/BM.2011.020","article-title":"The paraoxonase 1, 2 and 3 in humans","volume":"21","author":"Rajkovic","year":"2011","journal-title":"Biochem Med (Zagreb"},{"key":"R2-14-20241212","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/iub.347","article-title":"Human tissue distribution of paraoxonases 1 and 2 mRNA","volume":"62","author":"Mackness","year":"2010","journal-title":"IUBMB Life"},{"key":"R3-14-20241212","doi-asserted-by":"crossref","first-page":"7649","DOI":"10.1074\/jbc.M512594200","article-title":"The histidine 115-histidine 134 dyad mediates the lactonase activity of mammalian serum paraoxonases","volume":"281","author":"Khersonsky","year":"2006","journal-title":"J Biol Chem"},{"key":"R4-14-20241212","doi-asserted-by":"crossref","first-page":"e0144579","DOI":"10.1371\/journal.pone.0144579","article-title":"An engineered version of human PON2 opens the way to understand the role of its post-translational modifications in modulating catalytic activity","volume":"10","author":"Mandrich","year":"2015","journal-title":"PLoS One"},{"key":"R5-14-20241212","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1002\/jat.789","article-title":"The active site of human paraoxonase (PON1)","volume":"21","author":"Josse","year":"2001","journal-title":"J Appl Toxicol"},{"key":"R6-14-20241212","doi-asserted-by":"crossref","first-page":"44444","DOI":"10.1074\/jbc.M105660200","article-title":"Paraoxonase-2 is a ubiquitously expressed protein with antioxidant properties and is capable of preventing cell-mediated oxidative modification of low density lipoprotein","volume":"276","author":"Ng","year":"2001","journal-title":"J Biol Chem"},{"key":"R7-14-20241212","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1161\/01.ATV.21.4.542","article-title":"Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids","volume":"21","author":"Reddy","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R8-14-20241212","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.abb.2007.02.015","article-title":"Estrogen esters as substrates for human paraoxonases","volume":"461","author":"Teiber","year":"2007","journal-title":"Arch Biochem Biophys"},{"key":"R9-14-20241212","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S0009-9120(74)91914-6","article-title":"Serum arylesterase isoenzymes in chronic hepatitis","volume":"7","author":"Burlina","year":"1974","journal-title":"Clin Biochem"},{"key":"R10-14-20241212","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2459\/JCM.0b013e328354e3ac","article-title":"The growing importance of PON1 in cardiovascular health: A review","volume":"13","author":"Macharia","year":"2012","journal-title":"J Cardiovasc Med (Hagerstown"},{"key":"R11-14-20241212","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1620\/tjem.212.133","article-title":"Decreased total antioxidant response and increased oxidative stress in Behcet's disease","volume":"212","author":"Isik","year":"2007","journal-title":"Tohoku J Exp Med"},{"key":"R12-14-20241212","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1097\/IAE.0b013e31822529b1","article-title":"Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein","volume":"32","author":"Javadzadeh","year":"2012","journal-title":"Retina"},{"key":"R13-14-20241212","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/sj.eye.6703062","article-title":"Serum PON1 arylesterase activity in relation to hyperhomocysteinaemia and oxidative stress in young adult central retinal venous occlusion patients","volume":"22","author":"Angayarkanni","year":"2008","journal-title":"Eye (Lond"},{"key":"R14-14-20241212","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s10238-009-0084-7","article-title":"Antioxidant potential, paraoxonase 1, ceruloplasmin activity and C-reactive protein concentration in diabetic retinopathy","volume":"10","author":"Nowak","year":"2010","journal-title":"Clin Exp Med"},{"key":"R15-14-20241212","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.freeradbiomed.2009.01.012","article-title":"Expression and activity of paraoxonase 1 in human cataractous lens tissue","volume":"46","author":"Hashim","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"R16-14-20241212","first-page":"634","article-title":"Color and solubility of the proteins of human cataracts","volume":"7","author":"Pirie","year":"1968","journal-title":"Invest Ophthalmol"},{"key":"R17-14-20241212","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1515\/CCLM.2008.046","article-title":"Relationship between thiolactonase activity and hyperhomocysteinemia according to MTHFR gene polymorphism in Tunisian Beh\u00e7et's disease patients","volume":"46","author":"Koubaa","year":"2008","journal-title":"Clin Chem Lab Med"},{"key":"R18-14-20241212","doi-asserted-by":"crossref","first-page":"6810","DOI":"10.1167\/iovs.10-5312","article-title":"GLUT-1 expression in bovine retinal capillary endothelial cells and pericytes exposed to advanced glycation end products","volume":"51","author":"Barathi","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R19-14-20241212","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s12177-011-9057-7","article-title":"Comparative modeling of PON2 and analysis of its substrate binding interactions using computational methods","volume":"3","author":"Barathi","year":"2010","journal-title":"J Ocul Biol Dis Infor"},{"key":"R20-14-20241212","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1136\/bjophthalmol-2011-301370","article-title":"Homocysteine induces oxidative stress in young adult central retinal vein occlusion","volume":"96","author":"Bharathi Devi","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"R21-14-20241212","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.2337\/dc10-0132","article-title":"Homocysteinethiolactone and paraoxonase: Novel markers of diabetic retinopathy","volume":"33","author":"Barathi","year":"2010","journal-title":"Diabetes Care"},{"key":"R22-14-20241212","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3109\/08958378.2013.878007","article-title":"Plasma paraoxonase and arylesterase activities in smokers and smokeless tobacco users as maras powder","volume":"26","author":"Kurtul","year":"2014","journal-title":"Inhal Toxicol"},{"key":"R23-14-20241212","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.clinbiochem.2007.03.015","article-title":"Assessment of paraoxonase activity and lipid peroxidation levels in diabetic and senile subjects suffering from cataract","volume":"40","author":"Hashim","year":"2007","journal-title":"Clin Biochem"},{"key":"R24-14-20241212","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.arcmed.2012.08.012","article-title":"Human plasma paraoxonase 1 (PON1) arylesterase activity during aging: Correlation with susceptibility of LDL oxidation","volume":"43","author":"Mehdi","year":"2012","journal-title":"Arch Med Res"},{"key":"R25-14-20241212","doi-asserted-by":"crossref","first-page":"e101380","DOI":"10.1371\/journal.pone.0101380","article-title":"Paraoxonase enzyme protects retinal pigment epithelium from chlorpyrifos insult","volume":"9","author":"Jasna","year":"2014","journal-title":"PLoS One"},{"key":"R26-14-20241212","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.atherosclerosis.2007.03.001","article-title":"Effect of fenofibrate therapy on paraoxonase1 status in patients with low HDL-C levels","volume":"196","author":"Phuntuwate","year":"2008","journal-title":"Atherosclerosis"},{"key":"R27-14-20241212","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0886-3350(02)01841-2","article-title":"Increased levels of advanced glycation end products in human cataractous lenses","volume":"29","author":"Franke","year":"2003","journal-title":"J Cataract Refract Surg"},{"key":"R28-14-20241212","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.exger.2010.11.007","article-title":"Role of advanced glycation end products (AGEs) and receptor for AGEs (RAGE) in vascular damage in diabetes","volume":"46","author":"Yamagishi","year":"2011","journal-title":"Exp Gerontol"},{"key":"R29-14-20241212","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s592-001-8074-z","article-title":"Effect of glycation of high density lipoproteins on their physicochemical properties and on paraoxonase activity","volume":"38","author":"Ferretti","year":"2001","journal-title":"Acta Diabetol"},{"key":"R30-14-20241212","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00249-011-0779-z","article-title":"Docking and molecular dynamics simulation studies on glycation-induced conformational changes of human paraoxonase 1","volume":"41","author":"Saleem","year":"2012","journal-title":"Eur Biophys J"},{"key":"R31-14-20241212","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.2174\/092986711798347216","article-title":"Determinants of paraoxonase 1 status: Genes, drugs and nutrition","volume":"18","author":"Schrader","year":"2011","journal-title":"Curr Med Chem"}],"container-title":["Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/02223309-201745040-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T22:58:49Z","timestamp":1751497129000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijmr.org.in\/ocular-distribution-of-antioxidant-enzyme-paraoxonase-its-alteration-in-cataractous-lens-diabetic-retina\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.4103\/ijmr.ijmr_1284_14","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]}}}